PortfoliosLab logoPortfoliosLab logo
Scienture Holdings, Inc (SCNX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US80880X1046
IPO Date
Apr 27, 2010

Highlights

Market Cap
$43.74M
Enterprise Value
-$6.57B
EPS (TTM)
-$667.50
Total Revenue (TTM)
$431.61M
Gross Profit (TTM)
$331.47M
EBITDA (TTM)
-$43.50B
Year Range
$0.24 - $2.60
ROA (TTM)
-49.31%
ROE (TTM)
-59.20%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Scienture Holdings, Inc

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Scienture Holdings, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Scienture Holdings, Inc (SCNX) has returned -44.12% so far this year and -80.21% over the past 12 months. Over the last ten years, SCNX has returned -41.15% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Scienture Holdings, Inc

1D
18.31%
1M
-33.74%
YTD
-44.12%
6M
-66.45%
1Y
-80.21%
3Y*
-53.07%
5Y*
-64.12%
10Y*
-41.15%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Apr 27, 2010, SCNX's average daily return is +4.79%, while the average monthly return is +386.29%. At this rate, your investment would double in approximately 0.0 years.

Historically, 36% of months were positive and 64% were negative. The best month was May 2014 with a return of +73,650.0%, while the worst month was Jun 2011 at -63.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, SCNX closed higher 24% of trading days. The best single day was May 9, 2014 with a return of +14,900.0%, while the worst single day was Dec 1, 2011 at -76.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-10.92%-5.33%-33.74%-44.12%
2025-36.03%-31.52%-45.66%-35.42%-5.99%18.95%86.54%-49.74%-12.87%-8.65%-22.80%-14.87%-91.57%
2024-19.75%128.30%61.11%-41.80%10.23%70.02%-7.13%-18.39%-4.05%-3.03%0.00%-17.69%86.89%
20234.37%-0.86%-29.19%13.27%-16.21%210.71%-43.14%2.96%-7.98%-17.21%0.52%-11.17%-13.95%
2022-13.98%-13.30%57.39%-38.63%-8.92%4.62%2.47%-30.12%-2.59%-21.24%-36.52%-28.74%-82.94%
20214.54%13.02%-16.16%-16.98%-16.78%22.10%12.44%8.25%-8.48%-13.07%-22.66%-28.70%-55.39%

Benchmark Metrics

Scienture Holdings, Inc has an annualized alpha of 12463229.32%, beta of 0.49, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 28, 2010.

  • This stock participated in 228.13% of S&P 500 Index downside but only 183.77% of its upside — more exposed to losses than it benefited from rallies.
  • Beta of 0.49 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
12,463,229.32%
Beta
0.49
0.00
Upside Capture
183.77%
Downside Capture
228.13%

Return for Risk

Risk / Return Rank

SCNX ranks 35 for risk / return — below 35% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


SCNX Risk / Return Rank: 3535
Overall Rank
SCNX Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
SCNX Sortino Ratio Rank: 6262
Sortino Ratio Rank
SCNX Omega Ratio Rank: 6363
Omega Ratio Rank
SCNX Calmar Ratio Rank: 77
Calmar Ratio Rank
SCNX Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Scienture Holdings, Inc (SCNX) and compare them to a chosen benchmark (S&P 500 Index).


SCNXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.21

0.90

-1.11

Sortino ratio

Return per unit of downside risk

1.28

1.39

-0.10

Omega ratio

Gain probability vs. loss probability

1.18

1.21

-0.03

Calmar ratio

Return relative to maximum drawdown

-0.90

1.40

-2.30

Martin ratio

Return relative to average drawdown

-1.33

6.61

-7.93

Explore SCNX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Scienture Holdings, Inc provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%50.00%100.00%150.00%$0.00$2.00$4.00$6.00$8.00$10.0020242025
Dividends
Dividend Yield
PeriodTTM20252024
Dividend$0.00$0.00$9.50

Dividend yield

0.00%0.00%157.02%

Monthly Dividends

The table displays the monthly dividend distributions for Scienture Holdings, Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.00$0.00
2025$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2024$8.00$0.00$0.00$0.00$1.50$0.00$0.00$0.00$0.00$0.00$9.50

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Scienture Holdings, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Scienture Holdings, Inc was 99.85%, occurring on Mar 30, 2026. The portfolio has not yet recovered.

The current Scienture Holdings, Inc drawdown is 99.83%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.85%Jun 3, 20142960Mar 30, 2026
-99.5%Apr 30, 2010523May 24, 2012490May 9, 20141013

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Scienture Holdings, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Scienture Holdings, Inc is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SCNX relative to other companies in the Pharmaceutical Retailers industry. Currently, SCNX has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SCNX in comparison with other companies in the Pharmaceutical Retailers industry. Currently, SCNX has a P/B value of 0.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items